Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Metabolon, a diagnostics and services company, has filed a patent infringement lawsuit in the US District Court for the Western District of Wisconsin against Stemina Biomarker Discovery.
Subscribe to our email newsletter
The lawsuit seeks a ruling that Stemina’s services directly infringe on US patents related to global analysis of complex biological samples for the discovery of biomarkers and pathways associated with drug action, toxicity and disease, according to the company.
Metabolon, through the lawsuit, requests for monetary damages in addition to an order permanently enjoining Stemina from continued acts of infringement.
Metabolon has developed the technology to identify and measure all of the biochemicals in a biological sample through its proprietary global processing method.